Revenues buoyed by gSevelamar, margins by milestone payment: Dr. Reddys Labs (DRL) revenue increased by 2.7% YoY to Rs 38.1 bn in line with our estimates of Rs 38.2 bn) due to improved contribution from US business in the Global generics business.